German Pharma Company Adds Bitcoin to Treasury Reserves

The Frankfurt-based firm purchased an additional 100 BTC in May 2025, valued at approximately €10 million (~$10.8 million), expanding its group-wide digital asset reserve.

The company began its Bitcoin strategy in 2020 and now reinforces that commitment with this latest acquisition.

Managing Director Dominik Evertz described Bitcoin as a scarce, globally tradable asset that strengthens long-term financial stability.

READ MORE:

Bitcoin Targeting $120,000 While Altcoins Signal Historic Breakout Potential

He said the asset complements the company’s reserves and aligns with its future-focused strategy.

The post German Pharma Company Adds Bitcoin to Treasury Reserves appeared first on Coindoo.